N-3 polyunsaturated fatty acids: Prophylaxis and symptomatic therapy for oxaliplatin-induced peripheral neuropathy—A randomized, double-blind placebo controlled trial

Authors :: Mohammad Hossein Somi
Hormoz Ayromlou
Mohammad Asghari Jafarabadi
Zohreh Ghoreishi
Ali Esfahani
Source :: Journal of Clinical Oncology. 33:e14504-e14504
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: e14504 Background: Oxaliplatin induced peripheral neuropathy (OXIPN) is the major dose-limiting side effect of oxaliplatin. N-3 PUFAs have known neuroprotective property. This study was a randomize...

Tools